CRIS Current Research Information System

MANERBA, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.276
AS - Asia 1.831
EU - Europa 1.382
AF - Africa 161
SA - Sud America 110
OC - Oceania 7
Totale 5.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.259
VN - Vietnam 501
CN - Cina 478
SG - Singapore 475
IT - Italia 313
GB - Regno Unito 281
DE - Germania 151
SE - Svezia 109
HK - Hong Kong 108
IN - India 97
FR - Francia 85
BR - Brasile 84
RU - Federazione Russa 68
CH - Svizzera 67
UA - Ucraina 61
IE - Irlanda 56
TG - Togo 52
CI - Costa d'Avorio 42
NL - Olanda 41
FI - Finlandia 39
JP - Giappone 32
KR - Corea 29
ZA - Sudafrica 28
BG - Bulgaria 27
NG - Nigeria 24
JO - Giordania 21
EE - Estonia 19
BE - Belgio 16
PH - Filippine 14
TH - Thailandia 12
AR - Argentina 11
AT - Austria 11
ES - Italia 11
ID - Indonesia 11
TW - Taiwan 10
IQ - Iraq 8
MX - Messico 8
SA - Arabia Saudita 8
BD - Bangladesh 7
CA - Canada 7
PL - Polonia 7
AU - Australia 6
SC - Seychelles 6
PK - Pakistan 5
TR - Turchia 5
CO - Colombia 4
LT - Lituania 4
PY - Paraguay 4
RO - Romania 4
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BT - Bhutan 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.767
Salva come PNG Salva come JPEG
Città #
Singapore 334
Ashburn 304
Fairfield 246
Southend 244
Chandler 209
Woodbridge 138
Bologna 123
Ho Chi Minh City 106
Houston 106
Hong Kong 104
Santa Clara 100
Seattle 99
Hanoi 93
Wilmington 93
San Jose 92
Ann Arbor 80
Cambridge 75
Dong Ket 75
Bern 64
Beijing 57
Princeton 57
Dublin 56
Hefei 56
Lomé 52
Abidjan 42
Redmond 40
Boardman 36
Lauterbourg 33
New York 32
Helsinki 31
Jacksonville 31
Los Angeles 27
Sofia 27
Nanjing 26
Abeokuta 24
Tokyo 24
Westminster 23
Seoul 21
Shenyang 21
Amman 20
Padova 20
Buffalo 19
Da Nang 19
Berlin 17
Guangzhou 17
Haiphong 17
San Diego 17
Brussels 15
Council Bluffs 14
Frankfurt am Main 14
Jalandhar 14
Milan 14
Turin 12
Saint Petersburg 11
Tianjin 11
Shanghai 10
Changsha 9
Falls Church 9
Jinan 9
Yubileyny 9
Amsterdam 8
Des Moines 8
Falkenstein 8
Mülheim 8
Nanchang 8
Bremen 7
Chennai 7
Dallas 7
Florence 7
Haikou 7
Hangzhou 7
Jakarta 7
Nuremberg 7
São Paulo 7
Baghdad 6
Belo Horizonte 6
Düsseldorf 6
Hebei 6
Johannesburg 6
London 6
Redondo Beach 6
Rome 6
The Dalles 6
Turku 6
Warsaw 6
Biên Hòa 5
Brooklyn 5
Can Tho 5
Mahé 5
Nha Trang 5
Paris 5
Phoenix 5
Quận Bình Thạnh 5
Redwood City 5
Thái Nguyên 5
Tân Tiến 5
Wuhan 5
Bengaluru 4
Bühl 4
Dearborn 4
Totale 3.939
Salva come PNG Salva come JPEG
Nome #
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 275
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 272
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 232
Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. 229
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 222
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells 219
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells 215
Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. 213
LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells 212
Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment 210
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 209
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 200
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 197
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 197
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 193
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 189
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 182
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 181
Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir 175
Albumin-drug conjugates in the treatment of hepatic disorders. 168
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 167
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 165
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 152
Lactate Upregulates the Expression of DNA Repair Genes, Causing Intrinsic Resistance of Cancer Cells to Cisplatin 152
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 133
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases 131
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 116
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 111
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 107
null 101
RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer 87
null 78
null 71
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 55
null 51
Totale 5.867
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 31 22 114
2021/2022579 49 10 45 44 48 28 27 53 29 37 116 93
2022/2023817 61 125 26 107 78 54 28 34 134 26 37 107
2023/2024202 13 31 9 25 10 66 8 4 4 15 2 15
2024/2025780 44 75 62 76 135 34 52 39 20 71 37 135
2025/20261.815 171 173 134 180 192 92 163 69 500 141 0 0
Totale 5.867